首页> 美国卫生研究院文献>The International Journal of Angiology : Official Publication of the International College of Angiology Inc >Bilateral massive pulmonary thromboembolism in a young patient treated with supportive measures and an inferior vena cava filter with excellent outcome
【2h】

Bilateral massive pulmonary thromboembolism in a young patient treated with supportive measures and an inferior vena cava filter with excellent outcome

机译:一名年轻患者的双侧大面积肺血栓栓塞症采用支持性措施和下腔静脉滤过器治疗效果良好

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute pulmonary embolism (PE) is a common and often fatal disease with a mortality rate of more than 30% in untreated patients. There is a twofold increase in mortality in patients with massive PEs who do not receive treatment. Recurrent embolism is the most common cause of death. A 48-year-old woman presented to Tan Tock Seng Hospital, Singapore, on December 16, 2009, with a massive pulmonary thromboembolism. She was admitted to the intensive care unit and treated with supportive measures, ventilatory support, antibiotics and ionotropes. The patient was diagnosed with urosepsis with septicemic shock, disseminated intravascular coagulation, acute renal failure, high anion gap metabolic acidosis, iron-deficiency anemia secondary to menorrhagia, and a uterine mass with high cancer antigen 125, although malignancy was ruled out. Anticoagulation or thrombolysis could not be provided in view of coagulopathy. The patient subsequently underwent inferior vena cava filter insertion on December 31, 2009. The patient showed clinical improvement over the next two weeks with antibiotics and supportive measures. If there is a contraindication to anticoagulation or thrombolysis, massive pulmonary thromboembolism should be treated aggressively with supportive measures. Inferior vena cava filter insertion should be instituted early to prevent recurrent PE, which can be fatal. It may take weeks before the patient displays clinical improvement.
机译:急性肺栓塞(PE)是一种常见且经常致命的疾病,未经治疗的患者死亡率超过30%。没有接受治疗的大量PE患者的死亡率增加了两倍。复发性栓塞是最常见的死亡原因。 2009年12月16日,一名48岁的妇女因巨大的肺血栓栓塞症被送往新加坡的陈笃生医院。她被送入重症监护室,并接受了支持措施,通气支持,抗生素和离子药物治疗。尽管排除了恶性肿瘤,但该患者被诊断患有尿毒症并伴有败血症性休克,弥散性血管内凝血,急性肾功能衰竭,高阴离子间隙代谢性酸中毒,月经过多继发性缺铁性贫血和子宫癌,癌抗原为125。鉴于凝血病,无法提供抗凝或溶栓治疗。该患者随后于2009年12月31日接受了下腔静脉滤器插入术。在接下来的两周中,该患者在使用抗生素和支持措施的情况下表现出临床改善。如果存在抗凝或溶栓的禁忌症,应采取辅助措施积极治疗大量肺血栓栓塞。下腔静脉滤器应尽早插入以防止PE复发,这可能是致命的。患者可能需要数周才能显示出临床症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号